PharmaCyte Biotech Dividend
Dividend criteria checks 0/6
PharmaCyte Biotech does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$1.75 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
PharmaCyte Biotech (NASDAQ:PMCB) Is In A Strong Position To Grow Its Business
Mar 22PharmaCyte Biotech says CEO to step down, announces strategic review of business
Oct 07PharmaCyte Biotech reaches agreement with Iroquois to include 2 board of directors
Aug 15Is This A Good Time To Invest In PharmaCyte?
Jan 07PharmaCyte Biotech: Buy The 'Dump'
Aug 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if PMCB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PMCB's dividend payments have been increasing.
Dividend Yield vs Market
PharmaCyte Biotech Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (PMCB) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (PMCB) | n/a |
Notable Dividend: Unable to evaluate PMCB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PMCB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate PMCB's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PMCB has not reported any payouts.